Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK

por Lautsch, Dominik, Wang, Tongtong, Yang, Lingfeng, Rajpathak, Swapnil N.
Publicado 2019

Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1

por Velcheti, Vamsidhar, Hu, Xiaohan, Yang, Lingfeng, Pietanza, M. Catherine, Burke, Thomas
Publicado 2022

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus

por Weiss, Tracey, Iglay, Kristy, Gulati, Tania, Rajpathak, Swapnil, Yang, Lingfeng, Blonde, Lawrence
Publicado 2021

Prognostic Interplay Between COVID-19 and Heart Failure With Reduced Ejection Fraction

por Greene, STEPHEN J., LAUTSCH, DOMINIK, YANG, LINGFENG, TAN, XI, BRADY, JOANNE E.
Publicado 2022

Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan

por Leith, Andrea, Kim, Jeri, Ribbands, Amanda, Clayton, Emily, Yang, Lingfeng, Ghate, Sameer R.
Publicado 2022

Long-term training in diabetes-related knowledge, attitudes, and self-reported practice among diabetes liaison nurses

por Zhou, Wen, Huang, Jin, Yang, Lingfeng, Qiu, Tieying, Zhang, Yan, Liu, Fang, Zhou, Zhiguang
Publicado 2019

Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event

por Butler, Javed, Djatche, Laurence M., Sawhney, Baanie, Chakladar, Sreya, Yang, Lingfeng, Brady, Joanne E., Yang, Mei
Publicado 2020

N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction

por Januzzi, James L., Tan, Xi, Yang, Lingfeng, Brady, Joanne E., Yang, Mei, Banka, Puja, Lautsch, Dominik
Publicado 2021

Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five Eu...

por Leith, Andrea, Ribbands, Amanda, Kim, Jeri, Clayton, Emily, Gillespie-Akar, Liane, Yang, Lingfeng, Ghate, Sameer R.
Publicado 2022

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States

por Weiss, Tracey, Carr, Richard D, Pal, Sampriti, Yang, Lingfeng, Sawhney, Baanie, Boggs, Robert, Rajpathak, Swapnil, Iglay, Kristy
Publicado 2020

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

por Weiss, Tracey, Yang, Lingfeng, Carr, Richard D, Pal, Sampriti, Sawhney, Baanie, Boggs, Robert, Rajpathak, Swapnil, Iglay, Kristy
Publicado 2022

A survey on glycemic control rate of type 2 diabetes mellitus with different therapies and patients’ satisfaction in China

por Dong, Qiaoliang, Huang, Jin, Liu, Shunying, Yang, Lingfeng, Li, Juan, Li, Bei, Zhao, Xue, Li, Zaizhao, Wu, Liaofang
Publicado 2019

Anticoagulant and Antiplatelet Use Among Hemodialysis Patients in the United States Without Medicare

por Boggs, Robert, Yang, Lingfeng, Lautsch, Dominik, Ramey, Dena Rosen, Liu, Sarah, Atkins, G. Brandon, McMullan, Ciaran Joseph
Publicado 2022

Using Deep Learning to Identify High-Risk Patients with Heart Failure with Reduced Ejection Fraction

por Wang, Zhibo, Chen, Xin, Tan, Xi, Yang, Lingfeng, Kannapur, Kartik, Vincent, Justin L., Kessler, Garin N., Ru, Boshu, Yang, Mei
Publicado 2021

Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data

por Weiss, Tracey J., Rosen Ramey, Dena, Yang, Lingfeng, Liu, Xinyue, Patel, Mahesh J., Rajpathak, Swapnil, Bajwa, Ednan K., Lautsch, Dominik
Publicado 2022

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial(§)

por Gallant, Joel, Moyle, Graeme, Berenguer, Juan, Shalit, Peter, Cao, Huyen, Liu, Ya-Pei, Myers, Joel, Rosenblatt, Lisa, Yang, Lingfeng, Szwarcberg, Javier
Publicado 2017

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors

por Shore, Neal D., Laliberté, François, Ionescu-Ittu, Raluca, Yang, Lingfeng, Mahendran, Malena, Lejeune, Dominique, Yu, Louise H., Burgents, Joseph, Duh, Mei Sheng, Ghate, Sameer R.
Publicado 2021

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies

por Ivanoiu, Adrian, Pariente, Jérémie, Booth, Kevin, Lobello, Kasia, Luscan, Gerald, Hua, Lisa, Lucas, Prisca, Styren, Scot, Yang, Lingfeng, Li, David, Black, Ronald S., Brashear, H. Robert, McRae, Thomas
Publicado 2016

Single Dose of SHR-1222, a Sclerostin Monoclonal Antibody, in Healthy Men and Postmenopausal Women With Low Bone Mass: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalati...

por Dai, Zhijie, Fang, Pingfei, Yan, Xiang, Zhu, Ronghua, Feng, Qiong, Yan, Qiangyong, Yang, Lingfeng, Fan, Xiao, Xie, Yuting, Zhuang, Lihong, Feng, Sheng, Liu, Yantao, Zhong, Sheng, Yang, Zeyu, Sheng, Zhifeng, Zhou, Zhiguang
Publicado 2021

Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

por Amin, Asim, Plimack, Elizabeth R, Ernstoff, Marc S, Lewis, Lionel D, Bauer, Todd M, McDermott, David F, Carducci, Michael, Kollmannsberger, Christian, Rini, Brian I, Heng, Daniel Y C, Knox, Jennifer, Voss, Martin H, Spratlin, Jennifer, Berghorn, Elmer, Yang, Lingfeng, Hammers, Hans J
Publicado 2018